What if a gas used in anesthesia became a weapon against Alzheimer's disease? A recent study reveals that xenon, a noble gas, ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

Brain cells regenerate, inflammation could drop as much as 68% when seniors exercise regularly BRISTOL, England — As ...

Researchers have determined that healthcare providers increased their ability to make Alzheimer’s disease (AD) probability judgments on their patients when they used the PrecivityAD2™ blood biomarker ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...